Latest news
Incyte Corporation (INCY) Stock Price, News, Quote & History - Yahoo! Finance CanadaYahoo! Finance Canada · Sat, 08 Aug 2026 19:56:15 GMTIncyte (INCY) Could Be 5% Overvalued Following Opzelura Approval And Higher Guidance - simplywall.stsimplywall.st · Wed, 05 Aug 2026 08:51:44 GMTWeekly Recap: Incyte Q2 revenue surge and Opzelura second EU indication - TradingViewTradingView · Mon, 03 Aug 2026 11:33:04 GMTThe Bull Case For Incyte (INCY) Could Change Following New EU Opzelura Atopic Dermatitis Approval - webull.comwebull.com · Mon, 03 Aug 2026 01:38:09 GMTIncyte (INCY) Wins EU Approval For Opzelura In Adult Moderate Atopic Dermatitis - Yahoo FinanceYahoo Finance · Sat, 01 Aug 2026 07:00:00 GMTEarnings Beat: Incyte Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - simplywall.stsimplywall.st · Fri, 31 Jul 2026 07:00:00 GMTIncyte (INCY) Wins European Approval For Opzelura In Adult Atopic Dermatitis - simplywall.stsimplywall.st · Thu, 30 Jul 2026 07:00:00 GMTBoosted by CMS settlement, Incyte expects Opzelura to cross $1B in 2026 - Fierce PharmaFierce Pharma · Wed, 29 Jul 2026 14:30:50 GMT